Prolonged Washout Period for Avoiding Azilsartan-Induced Refractory Hypotension During General Anesthesia for a Patient With Renal Impairment.

Q3 Medicine
Takayuki Hojo, Yukifumi Kimura, Keiji Hashimoto, Takahito Teshirogi, Toshiaki Fujisawa
{"title":"Prolonged Washout Period for Avoiding Azilsartan-Induced Refractory Hypotension During General Anesthesia for a Patient With Renal Impairment.","authors":"Takayuki Hojo,&nbsp;Yukifumi Kimura,&nbsp;Keiji Hashimoto,&nbsp;Takahito Teshirogi,&nbsp;Toshiaki Fujisawa","doi":"10.2344/anpr-68-02-08","DOIUrl":null,"url":null,"abstract":"<p><p>Angiotensin receptor blockers (ARBs) are widely used to treat hypertension, but severe refractory hypotension during general anesthesia is a well-known complication associated with the continuation of ARBs during the perioperative period. It has therefore been recommended that ARBs be withheld for 24 hours before induction of general anesthesia. However, impaired renal function affects the pharmacokinetics of each ARB differently. The half-life of azilsartan is prolonged in accordance with the degree of renal impairment. Herein, we describe a patient with chronic kidney disease grade 3B who experienced severe refractory hypotension after induction of general anesthesia requiring administration of dopamine following inadequate responses to ephedrine and phenylephrine despite a 24-hour azilsartan washout period. When the same patient underwent general anesthesia for a subsequent surgery, azilsartan was withheld for 48 hours before induction, resulting in mild intraoperative hypotension that responded adequately to phenylephrine. Severe refractory hypotension during general anesthesia cannot always be avoided by holding azilsartan for 24 hours in patients with significant renal impairment. Therefore, a longer washout period may be preferable for patients regularly taking azilsartan who also have concurrent substantial renal impairment.</p>","PeriodicalId":7818,"journal":{"name":"Anesthesia progress","volume":"68 4","pages":"220-223"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674853/pdf/i0003-3006-68-4-220.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia progress","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2344/anpr-68-02-08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Angiotensin receptor blockers (ARBs) are widely used to treat hypertension, but severe refractory hypotension during general anesthesia is a well-known complication associated with the continuation of ARBs during the perioperative period. It has therefore been recommended that ARBs be withheld for 24 hours before induction of general anesthesia. However, impaired renal function affects the pharmacokinetics of each ARB differently. The half-life of azilsartan is prolonged in accordance with the degree of renal impairment. Herein, we describe a patient with chronic kidney disease grade 3B who experienced severe refractory hypotension after induction of general anesthesia requiring administration of dopamine following inadequate responses to ephedrine and phenylephrine despite a 24-hour azilsartan washout period. When the same patient underwent general anesthesia for a subsequent surgery, azilsartan was withheld for 48 hours before induction, resulting in mild intraoperative hypotension that responded adequately to phenylephrine. Severe refractory hypotension during general anesthesia cannot always be avoided by holding azilsartan for 24 hours in patients with significant renal impairment. Therefore, a longer washout period may be preferable for patients regularly taking azilsartan who also have concurrent substantial renal impairment.

延长洗脱期避免阿齐沙坦致肾功能损害患者全麻期间难治性低血压。
血管紧张素受体阻滞剂(ARBs)广泛用于治疗高血压,但全身麻醉期间严重难治性低血压是围手术期持续使用ARBs的常见并发症。因此,建议在全麻诱导前24小时不使用arb。然而,肾功能受损对每种ARB的药代动力学影响不同。阿兹沙坦的半衰期随肾脏损害程度而延长。在本文中,我们描述了一位3B级慢性肾病患者,他在诱导全身麻醉后出现了严重的难治性低血压,尽管阿齐沙坦有24小时的洗脱期,但由于麻黄碱和苯肾上腺素的反应不足,需要给予多巴胺。当同一患者在随后的手术中接受全身麻醉时,阿齐沙坦在诱导前48小时未使用,导致术中轻度低血压,对苯肾上腺素有充分反应。对于有明显肾功能损害的患者,阿齐沙坦维持24小时不能避免全麻时的严重难治性低血压。因此,对于定期服用阿兹沙坦同时存在严重肾功能损害的患者,较长的洗脱期可能是可取的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Anesthesia progress
Anesthesia progress Medicine-Medicine (all)
CiteScore
0.90
自引率
0.00%
发文量
32
期刊介绍: Anesthesia Progress is a peer-reviewed journal and the official publication of the American Dental Society of Anesthesiology. The journal is dedicated to providing a better understanding of the advances being made in the art and science of pain and anxiety control in dentistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信